We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current IGMS market cap is 86.85M. The company's latest EPS is USD -4.1439 and P/E is -0.36.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 509k | 651k | 497k | 1.25M | 516k |
| Operating Income | -66.76M | -65.12M | -53.86M | -51.36M | -64.39M |
| Net Income | -61.99M | -60.7M | -49.82M | -47.9M | -61.43M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 1.07M | 2.13M |
| Operating Income | -44.5M | -83.28M | -165.32M | -227.96M | -263.46M |
| Net Income | -43.13M | -81.36M | -165.16M | -221.1M | -246.42M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 474.35M | 423.41M | 376.13M | 336.5M | 304.51M |
| Total Liabilities | 220.49M | 220.18M | 214.88M | 214.14M | 225.56M |
| Total Equity | 253.86M | 203.23M | 161.25M | 122.36M | 78.95M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 261.35M | 408.63M | 298.13M | 513.5M | 423.41M |
| Total Liabilities | 21.12M | 26.82M | 53.22M | 226.24M | 220.18M |
| Total Equity | 240.23M | 381.82M | 244.91M | 287.26M | 203.23M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -144.22M | -192.23M | -42.42M | -79.79M | -118.18M |
| Investing | 83.05M | 68.36M | 8.65M | 33.18M | 46.16M |
| Financing | 114.67M | 115.07M | 152k | 767k | 1.97M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -45.12M | -67.3M | -124.34M | -5.85M | -192.23M |
| Investing | -203.24M | 57.71M | 14.82M | -225.64M | 68.36M |
| Financing | 282.26M | 214.78M | 2.48M | 219.38M | 115.07M |
| Market Cap | 86.85M |
| Price to Earnings Ratio | -0.36 |
| Price to Sales Ratio | 42.18 |
| Price to Cash Ratio | 0.8 |
| Price to Book Ratio | 0.44 |
| Dividend Yield | - |
| Shares Outstanding | 59.46M |
| Average Volume (1 week) | 571.79k |
| Average Volume (1 Month) | 1.01M |
| 52 Week Change | -85.05% |
| 52 Week High | 22.50 |
| 52 Week Low | 1.45 |
| Spread (Intraday) | 0.09 (5.81%) |
| Company Name | IGM Biosciences Inc |
| Address |
corporation trust center dover, delaware 19901 |
| Website | https://www.igmbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
